Fenlu Zhu, PhD
Assistant Professor
Locations
- Hematology and Oncology
Biography
Dr. Fenlu Zhu is an assistant professor of medicine (hematology and oncology) at the ³ΙΘΛΏμΚΦ. He received his PhD degree in molecular biology/virology from the Institute of Basic Medical Sciences in Beijing, China. He completed his post-doctoral fellowship in cellular immunology and started working on immunotherapy in the Blood and Marrow Transplant Laboratories at the ³ΙΘΛΏμΚΦ. He joined the faculty in the Department of Medicine at the ³ΙΘΛΏμΚΦ in 2017.
Dr. Zhu’s research interest has been focusing on immunotherapy especially preclinical process development and validations; large-scale cGMP manufacturing of cellular products including patient cell purification, expansion, transduction and formulation; product characterization and release testing such as phenotype, potency, purity and stability; technology transfer from research bench to clinical production; quality control, FDA regulations and FACT accreditations; SOP preparation and investigational new drug (IND) applications; immune monitoring and correlative studies pre and after cellular therapy infusion. Pre-clinical process developments have been conducted, INDs have been approved and cellular therapy products have been manufactured under cGMP for clinical trials including manufacturing multi-specific (EBV, CMV and Adenovirus) cytotoxic T lymphocytes (CTL) in G-Rex system and using those cells to treat and prevent viral infections in transplant patients, and development and manufacture of the CD20_CD19 dual chimeric antigen receptor (CAR) T cells using CliniMACS Prodigy Device for the treatment of B cell malignancies.